Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Am Heart J. 2010 Dec;160(6):1023-8. doi: 10.1016/j.ahj.2010.09.002.
This document examines the formation, structure, and principles guiding the use of electrocardiogram (ECG) data sets obtained during thorough QT studies that have been derived from the ECG Warehouse of the Cardiac Safety Research Consortium (CSRC). These principles are designed to preserve the fairness and public interest of access to these data, commensurate with the mission of the CSRC. The data sets comprise anonymized XML formatted digitized ECGs and descriptive variables from placebo and positive control arms of individual studies previously submitted on a proprietary basis to the US Food and Drug Administration by pharmaceutical sponsors. Sponsors permit the release of these studies into the public domain through the CSRC on behalf of the Food and Drug Administration's Critical Path Initiative and public health interest. For algorithm research protocols submitted to and approved by CSRC, unblinded "training" ECG data sets are provided for algorithm development and for initial evaluation, whereas separate blinded "testing" data sets are used for formal algorithm evaluation in cooperation with the CSRC according to methods detailed in this document.
本文件探讨了在全面 QT 研究中获得的心电图 (ECG) 数据集的形成、结构和指导使用原则,这些数据集源自心脏安全研究联盟 (CSRC) 的心电图仓库。这些原则旨在保护公平公正地获取这些数据的机会,同时符合 CSRC 的使命。数据集包括匿名的 XML 格式数字化 ECG 和描述性变量,来自先前以专有方式向美国食品和药物管理局提交的单个研究的安慰剂和阳性对照臂。赞助商允许通过 CSRC 将这些研究发布到公共领域,代表食品和药物管理局的关键路径倡议和公共卫生利益。对于提交给 CSRC 并获得批准的算法研究方案,提供了未屏蔽的“训练”ECG 数据集,用于算法开发和初步评估,而单独的屏蔽“测试”数据集则根据本文详细方法与 CSRC 合作用于正式的算法评估。